Feed / IMRX

Immuneering Corporation

IMRX

Healthcare · 5.23 +1.1% today

Jodie read · what matters now

Immuneering Corporation is being tracked across filings, market groups, and disclosed business relationships.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to IMRX, and whether its market group begins moving.

Latest storyNo Struct brief yetJodie is monitoring new filings.
Disclosed connections8 verified links5 additional receipts in Pro
Organic co-movement groupOncology Clinical Trials · LeaderLast observed group; it is between live snapshots · See active groups →

Who this business touches

The relationships behind IMRX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

REGNRegeneron Pharmaceuticals, Inc.partnerFull receipt with Pro →
LLYEli Lilly and CompanypartnerFull receipt with Pro →
AZNAstraZeneca PLCpartnerFull receipt with Pro →

Filing peers

Companies whose filings use similar operating language.

You can see the shape of the network here. Pro opens 5 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

IMRX is currently a Leader in the organic co-movement group Oncology Clinical Trials. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for IMRX; it is not active in the latest market snapshot.

Theme membership history

No durable theme membership has been observed for this name yet.